title: No inhibitory effects of (-)-epigallocatechin gallate and lycopene on spontaneous hepatotumorigenesis in C3H/HeN mice.
abstract: Although several studies have indicated that (-)-epigallocatechin gallate (EGCG) and lycopene, representative dietary antioxidants, inhibit chemically induced animal tumorigenesis, only a few studies have examined the inhibitory effects of these compounds on spontaneous liver tumorigenesis in rodents. In this study, we investigated the inhibitory effects of these compounds on the formation of spontaneous liver tumors in C3H/HeN mice. We used xeroderma pigmentosum group A (XPA) gene-deficient mice to simultaneously examine whether the knockout mice could be used as a sensitive animal model. Inaddition, we examined the levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG)--a marker of reactive oxygen species-induced DNA injury--in liver tissue. Male XPA +/+, XPA +/-, and XPA -/- mice with a C3H/HeN genetic background were divided into 3 groups: control, EGCG, and lycopene. Autopsy at 18 months of age revealed that EGCG and lycopene did not exhibit obvious suppressive effects on the development of liver tumors in any XPA genotype; further, the XPA genotype did not influence any susceptibility to liver tumors. With regard to 8-OHdG levels in non-tumorous liver tissue at 8 months of age, EGCG showed no significant inhibitory effects and lycopene showed significant inhibitory effects only in XPA +/- mice. The present study demonstrates that contrary to previous reports of the inhibitory effects of EGCG and lycopene on the development of various carcinogen-induced animal tumors, these compounds exert no chemopreventive effects on spontaneous liver tumorigenesis in C3H/HeN mice. EGCG and lycopene may inhibit carcinogen-induced tumors through properties other than their antioxidant abilities.
authors.affiliation: Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan. ytakaha-tky@umin.ac.jp
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Hara
authors.forename: Masayo
authors.initials: M
authors.lastname: Imanaka
authors.forename: Hideki
authors.initials: H
authors.lastname: Wanibuchi
authors.forename: Kiyoji
authors.initials: K
authors.lastname: Tanaka
authors.forename: Takatoshi
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Shigeo
authors.initials: S
authors.lastname: Mori
authors.forename: Toshio
authors.initials: T
authors.lastname: Fukusato
mesh_terms: D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology; D002338:Carotenoids / Q000494:pharmacology*; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D008114:Liver Neoplasms, Experimental / Q000473:pathology / Q000517:prevention & control*; D000077276:Lycopene; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D018345:Mice, Knockout; D051760:Xeroderma Pigmentosum Group A Protein / Q000235:genetics
chemical_list: D016588:Anticarcinogenic Agents; D000975:Antioxidants; D051760:Xeroderma Pigmentosum Group A Protein; C497315:Xpa protein, mouse; D002338:Carotenoids; D002392:Catechin; C045651:epigallocatechin gallate; D000077276:Lycopene